196 related articles for article (PubMed ID: 9494860)
1. Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
Doğan UB; Cindoruk M; Dumlu S; Unlü R; Unal S
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):476-7. PubMed ID: 9494860
[No Abstract] [Full Text] [Related]
2. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study.
Poo JL; Rosas-Romero R; Montemayor AC; Isoard F; Uribe M
J Gastroenterol; 2003; 38(1):45-51. PubMed ID: 12560921
[TBL] [Abstract][Full Text] [Related]
3. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases.
Lin CC; Huang JF; Tsai LY; Huang YL
Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099
[TBL] [Abstract][Full Text] [Related]
4. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
5. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
[TBL] [Abstract][Full Text] [Related]
6. CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels.
Frezza EE; Gerunda GE; Farinati F; DeMaria N; Galligioni A; Plebani F; Giacomin A; Van Thiel DH
Hepatogastroenterology; 1994 Aug; 41(4):367-9. PubMed ID: 7959573
[TBL] [Abstract][Full Text] [Related]
7. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
J Med; 1984; 15(2):149-60. PubMed ID: 6096471
[TBL] [Abstract][Full Text] [Related]
8. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; QUE GS
Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
[No Abstract] [Full Text] [Related]
9. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; Qué GS
Neth J Med; 1976; 19(1):15-8. PubMed ID: 55984
[No Abstract] [Full Text] [Related]
10. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma.
Liaw KY; Lee PH; Wu FC; Tsai JS; Lin-Shiau SY
Am J Gastroenterol; 1997 Dec; 92(12):2260-3. PubMed ID: 9399766
[TBL] [Abstract][Full Text] [Related]
11. Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma.
Nagasue N; Kolno H; Chang YC; Nakamura T
Oncology; 1989; 46(5):293-6. PubMed ID: 2550861
[TBL] [Abstract][Full Text] [Related]
12. The copper/zinc ratio in patients with hepatocellular carcinoma.
Ebara M; Fukuda H; Saisho H
J Gastroenterol; 2003; 38(1):104-5. PubMed ID: 12560932
[No Abstract] [Full Text] [Related]
13. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
14. Primary liver cell carcinoma and post-necrotic cirrhosis associated with Australia antigen and alpha-feto protein. (A case report).
Malaviya AN; Nayak NC
J Assoc Physicians India; 1971 Oct; 19(10):697-700. PubMed ID: 4332064
[No Abstract] [Full Text] [Related]
15. [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus].
Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen CY
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):74-5. PubMed ID: 18226355
[No Abstract] [Full Text] [Related]
16. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
Chan KK; Chlebowski RT; Tong M; Chen HS; Gross JF; Bateman JR
Cancer Res; 1980 Apr; 40(4):1263-8. PubMed ID: 6244090
[No Abstract] [Full Text] [Related]
18. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin III and hepatocellular carcinoma.
Lefrère JJ; Conard J; Lerable J; Samama M
Thromb Haemost; 1989 Sep; 62(2):817. PubMed ID: 2554522
[No Abstract] [Full Text] [Related]
20. [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].
Takezaki E; Murakami S; Kagawa K; Omori H; Nishibayashi H
Gan No Rinsho; 1990 Jan; 36(1):19-22. PubMed ID: 2153846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
